Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: Inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model

Archives of Oral Biology

Volumn 52, Issue 3, 2007, Pages 273-279

  Heber, Elisa M ^a   Aromando, Romina F ^a,b   Trivillin, Verónica A ^a   Itoiz, Maria E ^a,b   Nigg, David W ^c   Kreimann, Erica L ^a   Schwint, Amanda E ^a  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c IDAHO NATIONAL LABORATORY   (United States)

Author keywords

BNCT; DNA synthesis; Hamster cheek pouch; Oral cancer; Precancerous tissue

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; DNA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL TRANSFORMATION; DISEASE MODEL; DRUG ANTAGONISM; HAMSTER; METHODOLOGY; MOUTH TUMOR; MULTIPLE CANCER; NEUTRON CAPTURE THERAPY; PATHOLOGY; PRECANCER; RADIATION DOSE; SYRIAN HAMSTER;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BORON NEUTRON CAPTURE THERAPY; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CRICETINAE; DISEASE MODELS, ANIMAL; DNA, NEOPLASM; MESOCRICETUS; MOUTH NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; PRECANCEROUS CONDITIONS; RADIOTHERAPY DOSAGE;

CRICETINAE;

EID: 33846216481     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2006.10.007     Document Type: Article

References (28)

1. Coderre J.A., and Morris G.M. The radiation biology of boron neutron capture therapy. Radiat Res 151 (1999) 1-18
2. González S.J., Bonomi M.R., Santa Cruz G.A., Blaumann H.R., Calzetta Larrieu O.A., Menéndez P., et al. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome. Appl Radiat Isotopes 61 (2004) 1101-1105
3. Kato I., Ono K., Sakurai Y., Ohmae M., Maruhashi A., Imahori Y., et al. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isotopes 61 (2004) 1069-1073
4. Barth R.F., Coderre J.A., Vicente M.G.H., and Blue T.E. Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 11 (2005) 3987-4002
5. Kreimann E.L., Itoiz M.E., Dagrosa A., Garavaglia R., Farías S., Batistoni D., et al. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Cancer Res 61 (2001) 8775-8781
6. Morris L. Factors influencing experimental carcinogenesis in the hamster cheek pouch. J Dent Res 40 (1961) 3-15
7. Kreimann E.L., Itoiz M.E., Longhino J., Blaumann H., Calzetta O., and Schwint A.E. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model. Cancer Res (Adv Brief) 61 (2001) 8638-8642
8. Trivillin V.A., Heber E.M., Itoiz M.E., Nigg D., Calzetta O., Blaumann H., et al. Radiobiology of BNCT mediated by GB-10 and GB-10 + BPA in experimental oral cancer. Appl Radiat Isotopes 61 (2004) 939-945
9. Trivillin V.A., Heber E.M., Nigg D.W., Itoiz M.E., Calzetta O., Blaumann H., et al. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Radiat Res 166 (2006) 387-396
10. Schwint A.E., Folco A., Morales A., Cabrini R.L., and Itoiz M.E. AgNOR mark epithelial foci in malignant transformation in hamster cheek pouch carcinogenesis. J Oral Pathol Med 25 (1996) 20-24
11. Raimondi A., Cabrini R., and Itoiz M.E. Ploidy analysis of field cancerization and cancer development in the hamster cheek pouch carcinogenesis model. J Oral Pathol Med 34 (2005) 227-231
12. Barth R.F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2, and CNS-1 gliomas. J Neuro-Oncol 36 (1998) 91-102
13. Dhooge J., De-Vos M., and Van-Cauwenberge P.B. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 108 (1998) 250-256
14. Smith D., and Haffty B.G. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiat Oncol Invest 7 (1999) 125-144
15. Braakhuis B.J.M., Tabor M.P., Kummer J.A., Leemans C.R., and Brakenhoff R.H. A genetic explanation of Slaughter's concept of field cancerization. Cancer Res 63 (2003) 1727-1730
16. Coderre J.A., Morris G.M., Kalef-Ezra J., Micca P.L., Ma R., Youngs K., et al. The effects of boron neutron capture therapy irradiation on oral mucosa: evaluation using a rat tongue model. Radiat Res 152 (1999) 113-118
17. 10) compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch. Arch Oral Biol 49 (2004) 313-324
18. Oliveira N.G., Castro M., Rodrigues A.S., Goncalves I.C., Cassapo R., Fernandes A.P., et al. Evaluation of the genotoxic effects of the boron neutron capture reaction in human melanoma cells using the cytokinesis block micronucleus assay. Mutagenesis 16 (2001) 369-375
19. Ono K., Masunaga S.I., Kinashi Y., Takagaki M., Akaboshi M., Kobayashi T., et al. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int J Radiat Biol Phys 34 (1996) 1081-1086
20. Kamida A., Obayashi S., Kato I., Ono K., Suzuki M., Nagata K., et al. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model. Int J Radiat Biol 82 (2006) 21-29
21. Dolbeare F., Gratzner H., Pallavicini M.G., and Gray J.W. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 80 (1983) 5573-5577
22. Shklar G., Eisenberg E., and Flynn E. Immunoenhancing agents and experimental leukoplakia and carcinoma of the buccal pouch. Prog Exp Tumor Res 24 (1979) 269-282
23. Sternberg L.A., Hardy P.H., Cuculis J.J., and Meyer H.G. The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 18 (1970) 315-330
24. World Health Organization Classification of Tumors. In: Barnes L., Everson J.W., Reichart P., and Sidransky D. (Eds). Pathology and genetics of head and neck tumors (2005), IARC Press
25. Gibson C.R., Staubus A.E., Barth R.F., Yang W., Ferketich A.K., and Moeschberger M.M. Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy. J Neurooncol 62 (2003) 3987-4002
26. Heber E.M., Trivillin V.A., Nigg D.W., Itoiz M.E., Gonzalez B.N., Rebagliati R.J., et al. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model. Arch Oral Biol 51 (2006) 922-929
27. Owens D.M., and Watt F.M. Contribution of stem cells and differentiated cells to epidermal tumors. Nat Rev/Cancer 3 (2003) 444-451
28. Elledge S.J. Cell cycle checkpoints: preventing an identity crisis. Science 274 (1996) 1664-1672